Jasper Therapeutics
Price & Volume
Stats
See moreOpen | $4.10 |
Previous Close | $4.23 |
Day Range | $3.97-$4.17 |
52W Range | $4.05-$30.70 |
Market Cap | $62.1M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.89 |
News
See moreYahoo Finance • last month
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Yahoo Finance • last month
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
Yahoo Finance • last month
Jasper Therapeutics to Present at Upcoming March Investor Conferences
About
CEO | Mr. Ronald A. Martell |
CFO | Mr. Herbert C. Cross CPA |
Address | 2200 Bridge Pkwy, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 64 |
